US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 37.980
  • +0.030+0.08%
Close Jul 19 16:00 ET
  • 37.530
  • -0.450-1.18%
Pre 08:00 ET
4.61BMarket Cap-11072P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
SYFOVRE137.47M79.77%
EMPAVELI25.61M14.86%
Licensing and other revenue9.25M5.37%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States396.59M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.33%